194 related articles for article (PubMed ID: 25196898)
1. Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor.
Yoshida M; Hazekawa M; Haraguchi T; Uchida T
Drug Dev Ind Pharm; 2015; 41(8):1387-92. PubMed ID: 25196898
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
[TBL] [Abstract][Full Text] [Related]
3. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products.
Tokuyama E; Matsunaga C; Yoshida K; Mifsud JC; Irie T; Yoshida M; Uchida T
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):382-7. PubMed ID: 19336932
[TBL] [Abstract][Full Text] [Related]
4. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
Harada T; Uchida T; Yoshida M; Kobayashi Y; Narazaki R; Ohwaki T
Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
[TBL] [Abstract][Full Text] [Related]
5. The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system.
Nakamura H; Uchida S; Sugiura T; Namiki N
Int J Pharm; 2015 Sep; 493(1-2):305-12. PubMed ID: 26216412
[TBL] [Abstract][Full Text] [Related]
6. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
[TBL] [Abstract][Full Text] [Related]
7. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor.
Hashimoto Y; Matsunaga C; Tokuyama E; Tsuji E; Uchida T; Okada H
Chem Pharm Bull (Tokyo); 2007 May; 55(5):739-46. PubMed ID: 17473460
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
9. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
Sugiura T; Uchida S; Namiki N
Chem Pharm Bull (Tokyo); 2012; 60(3):315-9. PubMed ID: 22382410
[TBL] [Abstract][Full Text] [Related]
10. [Comprehensive evaluation of palatability for commercial medicine by taste sensing system].
Uchida T
Yakugaku Zasshi; 2014; 134(3):317-23. PubMed ID: 24584008
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
[TBL] [Abstract][Full Text] [Related]
12. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
Matsui R; Uchida S; Namiki N
Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
Takano H; Uchida S; Kashiwagura Y; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
Chem Pharm Bull (Tokyo); 2019; 67(2):112-119. PubMed ID: 30713270
[TBL] [Abstract][Full Text] [Related]
14. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol.
Uchida T; Sugino Y; Hazekawa M; Yoshida M; Haraguchi T
Chem Pharm Bull (Tokyo); 2012; 60(8):949-54. PubMed ID: 22863696
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
[TBL] [Abstract][Full Text] [Related]
18. Taste masking microspheres for orally disintegrating tablets.
Xu J; Bovet LL; Zhao K
Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
20. Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
Sano S; Iwao Y; Kimura S; Noguchi S; Itai S
Int J Pharm; 2014 Jul; 468(1-2):234-42. PubMed ID: 24709215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
